文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

2012 - 2015年慢性疾病对新西兰成年人感染人偏肺病毒住院风险的影响

The Impact of Chronic Medical Conditions on the Risk of Human Metapneumovirus Hospitalizations in New Zealand Adults, 2012-2015.

作者信息

Aminisani Nayyereh, Wood Timothy, Waite Ben, Seeds Ruth, Jelley Lauren, Wong Conroy, Sue Huang Q

机构信息

Wallaceville Science Centre, Institute of Environmental Science and Research.

Department of Respiratory Medicine, Te Whatu Ora, Health NZ Counties Manukau, Auckland.

出版信息

J Infect Dis. 2025 Jul 16;232(Supplement_1):S59-S68. doi: 10.1093/infdis/jiaf226.


DOI:10.1093/infdis/jiaf226
PMID:40668093
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12265055/
Abstract

BACKGROUND: Unlike influenza, information on the risk of human metapneumovirus (HMPV) infections in adults with chronic medical conditions (CMCs) is less robust. METHODS: The SHIVERS project (Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance) performed a population-based surveillance of acute respiratory illness hospitalizations in Auckland, New Zealand, from 2012 to 2015. In this analysis, we linked these surveillance data to population-based administrative data to estimate the age- and ethnicity-adjusted risk of HMPV-associated hospitalization during the study period among adults by certain CMCs: chronic obstructive pulmonary disease, asthma, congestive heart failure, coronary artery disease, cerebrovascular accidents, diabetes mellitus, and end-stage renal disease. RESULTS: Overall, HMPV hospitalization rates were significantly higher across all ages and ethnic groups among adults with CMCs than those without any condition. In imputed analysis, the CMC with the highest risk of HMPV hospitalization across age groups was congestive heart failure (incidence rate ratio [IRR] range, 7.0-23.0), followed by coronary artery disease (IRR range, 4.2-9.1) and chronic obstructive pulmonary disease (IRR range, 6.7-11.9) in adults aged ≥50 years. The CMC with the highest risk of HMPV hospitalization was congestive heart failure in Māori/Pacific adults and chronic obstructive pulmonary disease in non-Māori/Pacific adults. Adults with ≥2 CMCs had a higher risk than those without CMCs; the risk varied by age group and ethnicity. CONCLUSIONS: Adults with specific or ≥2 CMCs are at increased risk of HMPV hospitalizations. Age and ethnicity affect this relationship for some CMCs but not all. Such populations may benefit from future HMPV prevention strategies.

摘要

背景:与流感不同,关于患有慢性疾病(CMC)的成年人感染人偏肺病毒(HMPV)风险的信息尚不充分。 方法:“寒颤”项目(南半球流感与疫苗效力研究及监测)于2012年至2015年在新西兰奥克兰开展了一项基于人群的急性呼吸道疾病住院监测。在本分析中,我们将这些监测数据与基于人群的行政数据相链接,以估算在研究期间特定慢性疾病(慢性阻塞性肺疾病、哮喘、充血性心力衰竭、冠状动脉疾病、脑血管意外、糖尿病和终末期肾病)患者中,按年龄和种族调整后的HMPV相关住院风险。 结果:总体而言,患有慢性疾病的成年人在所有年龄组和种族中的HMPV住院率均显著高于无任何疾病的成年人。在推算分析中,各年龄组中HMPV住院风险最高的慢性疾病是充血性心力衰竭(发病率比[IRR]范围为7.0 - 23.0),其次是≥50岁成年人中的冠状动脉疾病(IRR范围为4.2 - 9.1)和慢性阻塞性肺疾病(IRR范围为6.7 - 11.9)。在毛利/太平洋岛民成年人中,HMPV住院风险最高的慢性疾病是充血性心力衰竭;在非毛利/太平洋岛民成年人中则是慢性阻塞性肺疾病。患有≥2种慢性疾病的成年人比无慢性疾病的成年人风险更高;风险因年龄组和种族而异。 结论:患有特定慢性疾病或≥2种慢性疾病的成年人HMPV住院风险增加。年龄和种族对某些慢性疾病存在这种关联,但并非对所有慢性疾病都如此。这类人群可能会从未来的HMPV预防策略中受益。

相似文献

[1]
The Impact of Chronic Medical Conditions on the Risk of Human Metapneumovirus Hospitalizations in New Zealand Adults, 2012-2015.

J Infect Dis. 2025-7-16

[2]
The Burden of HMPV- and Influenza-Associated Hospitalizations in Adults in New Zealand Before and After the COVID-19 Pandemic, 2012-2023.

J Infect Dis. 2025-7-16

[3]
Respiratory Syncytial Virus and Human Metapneumovirus Respiratory Hospitalizations and Outcomes in Colorado Adults ≥50 Years of Age: 2016-2023.

J Infect Dis. 2025-7-16

[4]
Review: Knowledge Gained and Gaps in Understanding in the 25 Years Since Human Metapneumovirus Was First Identified as a Cause of Human Disease.

J Infect Dis. 2025-7-16

[5]
Multicenter Cross-sectional Study on the Epidemiology of Human Metapneumovirus in Italy, 2022-2024, With a Focus on Adults Over 50 Years of Age.

J Infect Dis. 2025-7-16

[6]
Characteristics of Human Metapneumovirus Infection Compared to Respiratory Syncytial Virus and Influenza Infections in Adults Hospitalized for Influenza-Like Illness in France, 2012-2022.

J Infect Dis. 2025-7-16

[7]
A Comparative Profile of the Burden of Human Metapneumovirus, Respiratory Syncytial Virus, and Influenza in the HIVE Cohort, 2010-2022.

J Infect Dis. 2025-7-16

[8]
Seasonal Incidence of Human Metapneumovirus in High-Risk Adults With Medically Attended Acute Respiratory Illness in a Rural US Community.

Influenza Other Respir Viruses. 2025-7

[9]
Human Metapneumovirus Epidemiology Among Middle-aged and Older Adults Hospitalized With Acute Respiratory Infection.

J Infect Dis. 2025-7-16

[10]
Outcomes of Human Metapneumovirus Infections in Nursing Home Residents: A Matched Cohort Analysis.

J Infect Dis. 2025-7-16

本文引用的文献

[1]
Human metapneumovirus infection is associated with a substantial morbidity and mortality burden in adult inpatients.

Heliyon. 2024-6-18

[2]
The burden of RSV, hMPV, and PIV amongst hospitalized adults in the United States from 2016 to 2019.

J Hosp Med. 2024-7

[3]
The Burden of Human Metapneumovirus- and Influenza-Associated Hospitalizations in Adults in New Zealand, 2012-2015.

J Infect Dis. 2024-10-16

[4]
Respiratory viral infections in the elderly.

Ther Adv Respir Dis. 2021

[5]
The inequity of morbidity: Disparities in the prevalence of morbidity between ethnic groups in New Zealand.

J Comorb. 2020-11-10

[6]
Respiratory Syncytial Virus-Associated Hospitalizations Among Adults With Chronic Medical Conditions.

Clin Infect Dis. 2021-7-1

[7]
Characteristics of human metapneumovirus infection in adults hospitalized for community-acquired influenza-like illness in France, 2012-2018: a retrospective observational study.

Clin Microbiol Infect. 2021-1

[8]
Risk of Severe Influenza Among Adults With Chronic Medical Conditions.

J Infect Dis. 2020-1-2

[9]
Missing data and multiple imputation in clinical epidemiological research.

Clin Epidemiol. 2017-3-15

[10]
Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance.

Influenza Other Respir Viruses. 2015-7

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索